Fairmount Funds Management as of Dec. 31, 2021
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 20 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix Com New | 13.4 | $41M | 2.5M | 16.25 | |
| Insmed Com Par $.01 (INSM) | 11.8 | $36M | 1.3M | 27.24 | |
| Enanta Pharmaceuticals (ENTA) | 9.6 | $29M | 387k | 74.78 | |
| Argenx Se Sponsored Adr (ARGX) | 9.1 | $28M | 79k | 350.19 | |
| Global Blood Therapeutics In | 7.2 | $22M | 743k | 29.27 | |
| Miragen Therapeutics (VRDN) | 6.2 | $19M | 944k | 19.77 | |
| Nuvalent Inc-a (NUVL) | 5.7 | $17M | 915k | 19.04 | |
| Keros Therapeutics (KROS) | 5.6 | $17M | 293k | 58.51 | |
| Cogent Biosciences (COGT) | 4.4 | $13M | 1.6M | 8.58 | |
| Instil Bio | 3.8 | $12M | 674k | 17.11 | |
| ACADIA Pharmaceuticals (ACAD) | 3.2 | $9.7M | 417k | 23.34 | |
| Tyra Biosciences (TYRA) | 3.0 | $9.1M | 645k | 14.07 | |
| Point Biopharma Global | 2.8 | $8.5M | 1.5M | 5.60 | |
| Amarin Corp Spons Adr New (AMRN) | 2.8 | $8.4M | 2.5M | 3.37 | |
| Biohaven Pharmaceutical Holding | 2.5 | $7.7M | 56k | 137.82 | |
| Iovance Biotherapeutics (IOVA) | 2.5 | $7.4M | 390k | 19.09 | |
| Axsome Therapeutics (AXSM) | 2.3 | $7.1M | 188k | 37.78 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.1 | $6.2M | 927k | 6.72 | |
| Astria Therapeutics (ATXS) | 1.6 | $4.9M | 912k | 5.39 | |
| Allakos (ALLK) | 0.5 | $1.4M | 147k | 9.79 |
